Posted by H. Sandra Chevalier-Batik
Is the HPV vaccine a victory for women’s health or the triumph of aggressive marketing?
Canadian reporters struggle to shed light on a muddled debate that’s as much about business as it is about health.
When federal Finance Minister Jim Flaherty announced $300 million in funding for a program to vaccinate girls and young women against the […]
Posted by H. Sandra Chevalier-Batik
In 1994, Congress passed the Dietary Supplement Health and Education Act (DSHEA).
The passage of DSHEA witnessed the biggest victory for consumers in the history of Congress. More letters were written to Congress than on any other piece of legislation in the history of our country. The voice of the people spoke louder on dietary […]
Posted by H. Sandra Chevalier-Batik
Information for Healthcare Professionals — Antipsychotics
FDA ALERT [6/16/2008]: FDA is notifying healthcare professionals that both conventional and atypical antipsychotics are associated with an increased risk of mortality in elderly patients treated for dementia-related psychosis.
In April 2005, FDA notified healthcare professionals that […]
Posted by H. Sandra Chevalier-Batik
Reporting any adverse events (unexpected side effects) to FDA after using a medical product, or other problems with any products that the agency regulates.
Printer-friendly PDF (366 KB)
On this page:
Tips for Reporting
Quick-Reference Chart for Reporting Problems to FDA
Types of Problems FDA Doesn’t Handle
Consumers play an important public health role by reporting to the Food and Drug […]
Posted by H. Sandra Chevalier-Batik
The Food and Drug Administration should rethink its rejection of the Declaration of Helsinki.
Later this year, the US Food and Drug Administration (FDA) will adopt new standards for human clinical trials conducted without its advance sign-off in foreign countries. The rules will govern whether data from such trials can be used in applications to market […]
Posted by H. Sandra Chevalier-Batik
The Food and Drug Administration has ordered Merck & Co. to correct numerous manufacturing deficiencies at its main vaccine plant, the latest in a string of setbacks for the drug maker.
The FDA released a warning letter sent to Merck’s chief executive, Richard T. Clark, that states FDA inspectors determined manufacturing rules are not being followed […]
Posted by H. Sandra Chevalier-Batik
HPV Report from the National Vaccine Information Center
National Vaccine Information Center (Debold V, Downey C, Fisher B). (2007). NVIC Analysis of […]
Posted by H. Sandra Chevalier-Batik
Are you trying to make a decision about whether to vaccinate yourself or your child?
en Espanol
Introductory Message
Parents Dos and Don’ts
Refusing […]
Posted by H. Sandra Chevalier-Batik
Get The Information You Need About Vaccine Reactions
VAERS Database Online
In 1986, Congress passed the National Childhood Vaccine Injury Act (PL-99-660) that among other things required healthcare providers […]
Posted by H. Sandra Chevalier-Batik
FDA News
FOR IMMEDIATE RELEASE
May 16, 2008
Media Inquiries:
Rita Chappelle, 301-827-6242
Consumer Inquiries:
888-INFO-FDA
FDA Obtains Permanent Injunction Against Scientific Laboratories, Inc.
Company manufactures and distributes unapproved and adulterated drugs
The U.S. Food and Drug Administration (FDA) today announced that Scientific Laboratories Inc., and its president, Rajeshwari Patel, and […]
Category Archives: 
BlogoSquare